psyence_fair

psyence_fair Academic and scientific conference/festival in August at Product Earth in the NAEC. Seminar zone

Would you like to support the legalisation of psychedelics for therapeutic use? Sign this petition to do your bit. Link ...
11/09/2025

Would you like to support the legalisation of psychedelics for therapeutic use? Sign this petition to do your bit. Link to sign at psychedelicare.eu

have a volunteer research assistant position going. What a lovely organisation to work for - and you’d be joining two o...
08/11/2024

have a volunteer research assistant position going. What a lovely organisation to work for - and you’d be joining two of our previous speakers!

study for heavy alcohol use. Would you like to reduce your drinking? UCL are currently recruiting for this trial, wher...
22/10/2024

study for heavy alcohol use. Would you like to reduce your drinking? UCL are currently recruiting for this trial, where DMT will be administered, to study its ability to ‘rewire’ maladaptive reward processes around alcohol.

If you have any questions about this study, please email [email protected] or give them a call on 0203 987 2576.

5MEO-DMT trial for treatment resistant depression. Currently recruiting - contract recruit@hmrlondon.com for further det...
01/06/2024

5MEO-DMT trial for treatment resistant depression. Currently recruiting - contract [email protected] for further details.

Calling all Psychiatrists! If you are, or you know a psychiatrist willing to take part, please consider the following im...
03/02/2023

Calling all Psychiatrists! If you are, or you know a psychiatrist willing to take part, please consider the following important piece of research.

Attitudes on psychedelics survey for European psychiatrists
This survey is part of a study that aims to explore attitudes on psychedelics in psychiatrists. It is conducted by a team from the University of Split School of Medicine, Croatia. The first part of this survey consists of a brief test in which you identify psychedelics substances, while the second part consists of survey items about attitudes on psychedelics.
Psychiatrists and other mental health experts have a crucial role in treating mental illness, therefore the rationale of the study is to explore their opinions on novel treatments such as psychedelic-assisted psychotherapy. So far no study has widely assessed psychiatrists’ attitudes by using a questionnaire. The instrument used for the survey, the Attitudes on Psychedelics Questionnaire (APQ) has previously been validated in the general population. This survey is its first use among psychiatrists. Its validation in this study will allow further use in exploring psychiatrists’ attitudes and will allow the comparison and determinants of attitudes on psychedelics among different groups, as well as to follow attitude trends over time.
You can access the survey here – filling it out takes about 5 minutes:
https://www.surveymonkey.com/r/2WFJVZ2

Your responses to this survey will remain fully anonymous. They will be used for research purposes only and analysed at a group level. Only members of the research team will have access to your data. This survey is fully voluntary and is meant for all individuals who are psychiatrists and are working within a European country. For more information about the survey, you can e-mail the principal investigator at [email protected]

Excited to share a new London-based clinical trial that is currently recruiting volunteers: the Safety and Tolerability ...
03/02/2023

Excited to share a new London-based clinical trial that is currently recruiting volunteers: the Safety and Tolerability of COMP360 (psilocybin) in Participants with Post-traumatic Stress Disorder (PTSD).

In this clinical study, participants receive a single 25mg dose of COMP360 psilocybin, given in conjunction with specialist psychological support. Participants are followed up for 12 weeks - the study will primarily assess safety but also and changes in PTSD symptoms and quality of life.

Please note, volunteers must have a diagnosis of PTSD. Please also note that the study excludes individuals with Complex PTSD.

Should you know individuals who might be eligible and interested in volunteering, please share the link and email address below:

Webpage: https://www.kcl.ac.uk/research/the-safety-and-tolerability-of-comp360-psilocybin-in-participants-with-post-traumatic-stress-disorder

Email: [email protected]

NOW RECRUITING - Imperial College London study - and Chronic pain is one of the leading causes of disability worldwi...
12/11/2022

NOW RECRUITING - Imperial College London study - and

Chronic pain is one of the leading causes of disability worldwide. Fibromyalgia, a condition characterised by widespread chronic pain, remains poorly understood with limited options for treatment. Psilocybin may provide an opportunity to affect the personal impact of pain in people living with fibromyalgia, and here, we wish to better understand how it may work.
Contact the study team: [email protected]. Please only contact this email address with queries related to the PsiloPain study.
For all other enquiries please email [email protected].

NOW RECRUITINGDr Teordini of London South Bank University is researching the perceived effects of microdosing psychedeli...
12/11/2022

NOW RECRUITING
Dr Teordini of London South Bank University is researching the perceived effects of microdosing psychedelics on wellbeing and gut health.


You don’t need to have taken these drugs to participate, although anyone who has would also contribute greatly!
The survey is completely confidential and takes 5/10 minutes.

Address

NAEC
Warwick
CV82LZ

Website

Alerts

Be the first to know and let us send you an email when psyence_fair posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to psyence_fair:

Shortcuts

Share

Category